Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. Mai 2022 07:00 ET | Quelle: Applied Therapeutics

Applied Therapeutics to Present at the UBS Global Healthcare Conference

NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
12. Mai 2022 06:59 ET | Quelle: Applied Therapeutics

Applied Therapeutics Reports First Quarter 2022 Financial Results

NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
05. Mai 2022 07:30 ET | Quelle: Applied Therapeutics

Applied Therapeutics to Present Data on AT-007 Treatment in SORD Deficiency at the 2022 Annual Meeting of the Peripheral Nerve Society

Sorbitol correlates with disease severity in patients with SORD DeficiencyAT-007 treatment substantially reduced sorbitol levels in a pilot study in SORD DeficiencySorbitol elevation results in...
04. April 2022 07:30 ET | Quelle: Applied Therapeutics

Applied Therapeutics to Present at the 43rd Annual Meeting of the Society for Inherited Metabolic Disorders

NEW YORK, April 04, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
16. März 2022 07:30 ET | Quelle: Applied Therapeutics

Applied Therapeutics to Present at the 2022 Annual Clinical Genetics Meeting of the American College of Molecular Genetics and Genomics

NEW YORK, March 16, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
10. März 2022 07:30 ET | Quelle: Applied Therapeutics

Applied Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results

NEW YORK, March 10, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
01. März 2022 07:00 ET | Quelle: Applied Therapeutics

Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences

NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
28. Februar 2022 07:30 ET | Quelle: Applied Therapeutics

Applied Therapeutics Supports 15th Annual Rare Disease Day

NEW YORK, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
10. Februar 2022 07:00 ET | Quelle: Applied Therapeutics

Applied Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
03. Januar 2022 07:00 ET | Quelle: Applied Therapeutics

Applied Therapeutics Provides Regulatory Update on Galactosemia Program

NEW YORK, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...

Vorherige Seite

Nächste Seite